Literature DB >> 1239379

Cellular RNA and influenza-virion RNA are synthesized from different pyrimidine-nucleoside-triphosphate pools in chick-embryo cells.

J W Dämmgen, C Scholtissek.   

Abstract

Chick embryo cells infected with an influenza A (fowl plague) virus have been labelled with (3H)-uridine for different lengths of time. Virion RNA and cellular RNA have been separated by specific hybridization with a surplus of unlabelled viral complementary RNA and RNase digestion. The ratio of the specific radioacticity in the UMP and CMP moieties of both types of RNA has been determined. Since the rate of approach to equilibrium of CMP to UMP labelling of both types of RNA is completely different it is concluded that cellular and virion RNA are synthesized using different pyrimidine nucleoside triphosphate pools.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1239379     DOI: 10.1111/j.1432-1033.1975.tb02423.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  4 in total

1.  Increased transcription and decreased degradation control and recovery of liver ribosomes after a period of protein starvation.

Authors:  R D Conde; M T Franze-Fernández
Journal:  Biochem J       Date:  1980-12-15       Impact factor: 3.857

2.  Determination of ribonucleoside triphosphate pools in influenza A virus-infected MDCK cells.

Authors:  S Stridh
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

3.  Free pyrimidine nucleotide pool of Ehrlich ascites-tumour cells. Compartmentation with respect to the synthesis of heterogeneous nuclear RNA and precursors to ribosomal RNA.

Authors:  D D Genchev; M B Kermekchiev; A A Hadjiolov
Journal:  Biochem J       Date:  1980-04-15       Impact factor: 3.857

4.  Incorporation of exogenous precursors into uridine nucleotides and ribonucleic acid. Nucleotide compartmentation in the renal cortex in vivo.

Authors:  P Cortes; N W Levin; F Dumler; K K Venkatachalam; C P Verghese; J Bernstein
Journal:  Biochem J       Date:  1979-09-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.